100 billion for chemo disrupter???The longs on this board have picked up on this years ago but I haven't seen highlighted in theralase nr until last week Best part of that news - when Dr. Jewett stated … “ The Theralase® technology, in a majority of cases, involves only one treatment versus months of therapy with immunotherapy and/or chemotherapy drugs and has only mild to moderate side effects that are easily managed and often resolve in days.” Dr. Arcandy Mandel also “ majority of patients achieved these efficacy responses after only one Ruvidar™ treatment. ”””. Folks this is a chemotherapy disrupter IMO